Pathophysiology of hepatic encephalopathy and future treatment options
Rev Gastroenterol Mex (Engl Ed). 2019 Apr-Jun;84(2):195-203.
doi: 10.1016/j.rgmx.2019.02.004.
Epub 2019 Apr 20.
[Article in
English,
Spanish]
Affiliations
- 1 Departamento de Gastroenterología, Instituto Nacional de Ciencias Médicas y Nutrición «Salvador Zubirán», Ciudad de México, México.
- 2 Departamento de Gastroenterología, Hospital General de México, Ciudad de México, México.
- 3 Departamento de Gastroenterología, Centro Médico Nacional Siglo XXI, Ciudad de México, México.
- 4 Departamento de Gastroenterología, Instituto Nacional de Ciencias Médicas y Nutrición «Salvador Zubirán», Ciudad de México, México; Unidad de Hepatología y Trasplante Hepático, Departamento de Gastroenterología, Instituto Nacional de Ciencias Médicas y Nutrición «Salvador Zubirán», Ciudad de México, México. Electronic address: detoal@yahoo.com.
Abstract
Understanding of the pathophysiology of hepatic encephalopathy has conditioned new treatment options. Ammonia detoxification in hepatic encephalopathy is regulated by two enzymes: glutaminase or glutamine synthetase. The first produces ammonia and the second detoxifies the ammonia, which is why treatments are aimed at glutaminase inhibition or glutamine synthetase activation. At present, we know that both enzymes are found not only in the liver, but also in the muscle, intestine, kidney, and brain. Therefore, current treatments can be directed at each enzyme at different sites. Awareness of those potential treatment sites makes different options of approach possible in the patient with hepatic encephalopathy, and each approach should be personalized.
Keywords:
Astrocito; Astrocyte; Detoxificación; Detoxification; Encefalopatía; Encephalopathy; Intestine; Intestino; Kidney; Muscle; Músculo; Riñón.
Copyright © 2019 Asociación Mexicana de Gastroenterología. Publicado por Masson Doyma México S.A. All rights reserved.
MeSH terms
-
Ammonia / metabolism
-
Enzyme Activators / therapeutic use
-
Enzyme Inhibitors / therapeutic use
-
Glutamate-Ammonia Ligase / drug effects
-
Glutaminase / antagonists & inhibitors
-
Hepatic Encephalopathy / physiopathology*
-
Hepatic Encephalopathy / therapy*
-
Humans
-
Hyperammonemia / physiopathology
-
Hyperammonemia / therapy
Substances
-
Enzyme Activators
-
Enzyme Inhibitors
-
Ammonia
-
Glutaminase
-
Glutamate-Ammonia Ligase